149 related articles for article (PubMed ID: 1663731)
21. Phosphonylmethyl ethers of acyclic nucleoside analogues: inhibitors of HSV-1 induced ribonucleotide reductase.
Cerný J; Votruba I; Vonka V; Rosenberg I; Otmar M; Holý A
Antiviral Res; 1990 May; 13(5):253-64. PubMed ID: 2168691
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy of the acquired immune deficiency syndrome (AIDS): acyclic nucleoside phosphonate analogues.
De Clercq E
Int J Immunopharmacol; 1991; 13 Suppl 1():91-8. PubMed ID: 1823910
[TBL] [Abstract][Full Text] [Related]
23. Long-acting therapy of viral retinitis with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine.
Flores-Aguilar M; Huang JS; Wiley CA; De Clercq E; Vuong C; Bergeron-Lynn G; Chandler B; Munguia D; Freeman WR
J Infect Dis; 1994 Mar; 169(3):642-7. PubMed ID: 8158041
[TBL] [Abstract][Full Text] [Related]
24. Therapeutic potential of Cidofovir (HPMPC, Vistide) for the treatment of DNA virus (i.e. herpes-, papova-, pox- and adenovirus) infections.
De Clercq E
Verh K Acad Geneeskd Belg; 1996; 58(1):19-47; discussion 47-9. PubMed ID: 8701600
[TBL] [Abstract][Full Text] [Related]
25. Antivirals for the treatment of herpesvirus infections.
De Clercq E
J Antimicrob Chemother; 1993 Jul; 32 Suppl A():121-32. PubMed ID: 8407694
[TBL] [Abstract][Full Text] [Related]
26. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.
Neyts J; De Clercq E
Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844
[TBL] [Abstract][Full Text] [Related]
27. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC) inhibits HIV-1 replication in epithelial cells, but not T-lymphocytes.
Srinivas RV; Connely M; Fridland A
Antiviral Res; 1997 Jun; 35(1):23-7. PubMed ID: 9224958
[TBL] [Abstract][Full Text] [Related]
28. Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine for long-acting therapy of viral retinitis.
Kuppermann BD; Assil KK; Vuong C; Besen G; Wiley CA; De Clercq E; Bergeron-Lynn G; Connor JD; Pursley M; Munguia D; Freeman WR
J Infect Dis; 1996 Jan; 173(1):18-23. PubMed ID: 8537656
[TBL] [Abstract][Full Text] [Related]
29. In vivo anti-papillomavirus activity of nucleoside analogues including cidofovir on CRPV-induced rabbit papillomas.
Christensen ND; Pickel MD; Budgeon LR; Kreider JW
Antiviral Res; 2000 Nov; 48(2):131-42. PubMed ID: 11114415
[TBL] [Abstract][Full Text] [Related]
30. DNA polymerase mutations in drug-resistant herpes simplex virus mutants determine in vivo neurovirulence and drug-enzyme interactions.
Andrei G; Fiten P; Froeyen M; De Clercq E; Opdenakker G; Snoeck R
Antivir Ther; 2007; 12(5):719-32. PubMed ID: 17713155
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic potential of phosphonylmethoxyalkylpurines and -pyrimidines as antiviral agents.
De Clercq E
Drugs Exp Clin Res; 1990; 16(7):319-26. PubMed ID: 1965499
[TBL] [Abstract][Full Text] [Related]
32. Suppression of rat adjuvant arthritis by some acyclic nucleotide analogs.
Zídek A; Holý A; Franková D; Otová B
Eur J Pharmacol; 1995 Nov; 286(3):307-10. PubMed ID: 8608793
[TBL] [Abstract][Full Text] [Related]
33. Treatment with intravenous (S)-1-[3-hydroxy-2-(phosphonylmethoxy)propyl]-cytosine of acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with AIDS.
Lalezari JP; Drew WL; Glutzer E; Miner D; Safrin S; Owen WF; Davidson JM; Fisher PE; Jaffe HS
J Infect Dis; 1994 Sep; 170(3):570-2. PubMed ID: 8077713
[TBL] [Abstract][Full Text] [Related]
34. Antiviral activity of anti-cytomegalovirus agents (HPMPC, HPMPA) assessed by a flow cytometric method and DNA hybridization technique.
Snoeck R; Schols D; Andrei G; Neyts J; De Clercq E
Antiviral Res; 1991 Jul; 16(1):1-9. PubMed ID: 1663725
[TBL] [Abstract][Full Text] [Related]
35. Resistance of herpes simplex virus type 1 against different phosphonylmethoxyalkyl derivatives of purines and pyrimidines due to specific mutations in the viral DNA polymerase gene.
Andrei G; Snoeck R; De Clercq E; Esnouf R; Fiten P; Opdenakker G
J Gen Virol; 2000 Mar; 81(Pt 3):639-48. PubMed ID: 10675401
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of the in vitro growth of Plasmodium falciparum by acyclic nucleoside phosphonates.
Smeijsters LJ; Franssen FF; Naesens L; de Vries E; Holý A; Balzarini J; de Clercq E; Overdulve JP
Int J Antimicrob Agents; 1999 Jun; 12(1):53-61. PubMed ID: 10389648
[TBL] [Abstract][Full Text] [Related]
37. (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication.
Snoeck R; Sakuma T; De Clercq E; Rosenberg I; Holy A
Antimicrob Agents Chemother; 1988 Dec; 32(12):1839-44. PubMed ID: 2854454
[TBL] [Abstract][Full Text] [Related]
38. Flow cytometric method for the detection of gpI antigens of varicella zoster virus and evaluation of anti-VZV agents.
Snoeck R; Schols D; Sadzot-Delvaux C; Cloes JM; Andrei G; De Clercq E; Piette J; Rentier B
J Virol Methods; 1992 Aug; 38(2):243-54. PubMed ID: 1325472
[TBL] [Abstract][Full Text] [Related]
39. Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
Snoeck R; Andrei G; De Clercq E
Eur J Clin Microbiol Infect Dis; 1996 Jul; 15(7):574-9. PubMed ID: 8874075
[TBL] [Abstract][Full Text] [Related]
40. Acyclic nucleotide analogues: synthesis, antiviral activity and inhibitory effects on some cellular and virus-encoded enzymes in vitro.
Holý A; Votruba I; Merta A; Cerný J; Veselý J; Vlach J; Sedivá K; Rosenberg I; Otmar M; Hrebabecký H
Antiviral Res; 1990 Jun; 13(6):295-311. PubMed ID: 1699493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
